• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用正电子发射断层扫描(PET)对癌症代谢进行成像。

Imaging Cancer Metabolism with Positron Emission Tomography (PET).

作者信息

Witney Timothy H, Lewis David Y

机构信息

Imaging Chemistry and Biology, King's College London, London, UK.

Molecular Imaging Laboratory, Cancer Research UK Beatson Institute, Glasgow, UK.

出版信息

Methods Mol Biol. 2019;1928:29-44. doi: 10.1007/978-1-4939-9027-6_2.

DOI:10.1007/978-1-4939-9027-6_2
PMID:30725448
Abstract

Positron emission tomography (PET) enables the noninvasive spatiotemporal analysis of cancer metabolism in vivo. Both natural and nonnatural PET tracers have been developed to assess metabolic pathways during tumorigenesis, cancer progression, and metastasis. Here we describe the dynamic in vivo PET/CT imaging of the glucose analogue [F]fluoro-2-deoxy-D-glucose (FDG), taking into consideration the methodology for alternative metabolic PET substrates.

摘要

正电子发射断层扫描(PET)能够在体内对癌症代谢进行无创的时空分析。天然和非天然的PET示踪剂均已被开发出来,用于评估肿瘤发生、癌症进展和转移过程中的代谢途径。在此,我们描述了葡萄糖类似物[F]氟-2-脱氧-D-葡萄糖(FDG)的动态体内PET/CT成像,并考虑了替代代谢PET底物的方法。

相似文献

1
Imaging Cancer Metabolism with Positron Emission Tomography (PET).利用正电子发射断层扫描(PET)对癌症代谢进行成像。
Methods Mol Biol. 2019;1928:29-44. doi: 10.1007/978-1-4939-9027-6_2.
2
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?在口腔/头颈部癌患者颈淋巴结病的诊断中,3'-脱氧-3'-(¹⁸F)氟胸苷的表现能优于2-脱氧-2-(¹⁸F)氟-D-葡萄糖正电子发射断层扫描/计算机断层扫描吗?
J Oral Maxillofac Surg. 2015 Jul;73(7):1420-8. doi: 10.1016/j.joms.2015.01.002. Epub 2015 Jan 13.
3
False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.肿瘤影像学中 2-[¹⁸F]-氟-2-脱氧-D-葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)的假阳性摄取。
Clin Radiol. 2011 Apr;66(4):366-82. doi: 10.1016/j.crad.2010.12.004. Epub 2011 Jan 26.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Quantification in clinical fluorodeoxyglucose positron emission tomography.临床氟脱氧葡萄糖正电子发射断层扫描中的定量分析。
Nucl Med Commun. 2004 Jul;25(7):647-50. doi: 10.1097/01.mnm.0000134327.85170.6b.
6
Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).使用正电子发射断层扫描(PET)对肿瘤代谢进行成像
Recent Results Cancer Res. 2016;207:177-205. doi: 10.1007/978-3-319-42118-6_8.
7
Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.除[¹⁸F]氟代脱氧葡萄糖之外的肿瘤正电子发射断层显像示踪剂及正电子发射断层显像中的新型定量方法。
Q J Nucl Med Mol Imaging. 2008 Mar;52(1):50-65.
8
Update on advances in molecular PET in urological oncology.泌尿外科肿瘤分子正电子发射断层显像进展综述
Jpn J Radiol. 2016 Jul;34(7):470-85. doi: 10.1007/s11604-016-0553-3. Epub 2016 May 24.
9
Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review.正电子发射断层显像/计算机断层扫描(PET/CT)在肿瘤学中使用除F-18-氟代脱氧葡萄糖(F-18-FDG)以外的示踪剂的诊断性能:一项基于证据的综述。
Clin Transl Oncol. 2014 Sep;16(9):770-5. doi: 10.1007/s12094-014-1168-8. Epub 2014 Mar 20.
10
Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.使用2-[F-18]氟-2-脱氧-D-葡萄糖的临床正电子发射断层扫描/计算机断层扫描扫描仪进行小动物肿瘤成像的初步经验。
Cancer Res. 2003 Oct 1;63(19):6252-7.

引用本文的文献

1
AI diagnostics in bone oncology for predicting bone metastasis in lung cancer patients using DenseNet-264 deep learning model and radiomics.使用DenseNet - 264深度学习模型和放射组学的骨肿瘤人工智能诊断在预测肺癌患者骨转移中的应用
J Bone Oncol. 2024 Sep 26;48:100640. doi: 10.1016/j.jbo.2024.100640. eCollection 2024 Oct.
2
Quantitative and Qualitative Radiological Assessment of Sarcopenia and Cachexia in Cancer Patients: A Systematic Review.癌症患者肌肉减少症和恶病质的定量与定性放射学评估:一项系统综述
J Pers Med. 2024 Feb 24;14(3):243. doi: 10.3390/jpm14030243.
3
Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosis.
新型磁共振成像技术在肝脏疾病诊断中的应用进展。
World J Gastroenterol. 2023 Jul 28;29(28):4384-4396. doi: 10.3748/wjg.v29.i28.4384.
4
Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma.在恶性胸膜间皮瘤的遗传模型中,石棉会加速疾病的发作。
Front Toxicol. 2023 Jun 27;5:1200650. doi: 10.3389/ftox.2023.1200650. eCollection 2023.
5
Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges.用于测量癌症患者身体成分的影像学方法:机遇与挑战。
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):56-67. doi: 10.1093/jncimonographs/lgad001.
6
Changing Role of PET/CT in Cancer Care With a Focus on Radiotherapy.PET/CT在癌症治疗中角色的转变:聚焦于放射治疗
Cureus. 2022 Dec 22;14(12):e32840. doi: 10.7759/cureus.32840. eCollection 2022 Dec.
7
Insights into the New Cancer Therapy through Redox Homeostasis and Metabolic Shifts.通过氧化还原稳态和代谢转变洞察新型癌症疗法
Cancers (Basel). 2020 Jul 7;12(7):1822. doi: 10.3390/cancers12071822.
8
Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer.磁共振成像引导的结直肠癌靶向治疗与诊断。
Cancer Biol Med. 2020 May 15;17(2):307-327. doi: 10.20892/j.issn.2095-3941.2020.0072.